Home
Conditions
Urologic Neoplasms

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies

Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Active, Not Recruiting

Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

NCT03682289

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +43 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

University of California, San Francisco San Francisco, California, United States

University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Active, Not Recruiting

A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer

NCT04917809

Conditions: Bladder Cancer, Carcinoma, FGFR3 Gene Mutation, +15 more
Locations: Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States

Memorial Sloan Kettering Commack (Limited Protocol Activities) Commack, New York, United States

View Trial Details

Active, Not Recruiting

A Phase II Study Bolstering Outcomes by Optimizing Immunotherapy Strategies With Evolocumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma (BOOST-RCC)

NCT06284564

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: UT Southwestern Medical Center Dallas, Texas, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Aerosolized Aldesleukin in Treating Patients With Lung Metastases

NCT01590069

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +34 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Perioperative Lenvatinib With Pembrolizumab in Patients With Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma

NCT04393350

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations: Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

View Trial Details

Active, Not Recruiting

Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord

NCT02713269

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +55 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study

NCT06350734

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +13 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Active, Not Recruiting

Computed Tomography Urography (CTU) vs Intravenous Urography (IVU) on Patients at Risk of Urothelial Tumors

NCT00567684

Conditions: Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +13 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors

NCT00479128

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +14 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

ARID1A and/or KDM6A Mutation and CXCL13 Expression

NCT04953104

Conditions: Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +48 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Urologic Neoplasms

Urologic Neoplasms trial results

Related conditions